Matthew T. Seibt
Nessuna posizione attualmente
Storia della carriera di Matthew T. Seibt
Precedenti posizioni note di Matthew T. Seibt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01/04/2018 | 01/03/2023 |
Formazione di Matthew T. Seibt
| The University of Texas at Austin | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- Matthew T. Seibt
- Esperienza
